Yesterday, July 28, 2016, 34 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $11,250.00 to $94,500,004.72.

Highlighted Stocks Traded by Insiders:

JB Hunt Transport Services (JBHT) - FREE Research Report

Garrison Earl Wayne, who is Director at JB Hunt Transport Services, sold 50,000 shares at $84.04 on July 28, 2016. Following this transaction, the Director owned 2.4 million shares meaning that the stake was reduced by 2.08% with the 50,000-share transaction.

The shares most recently traded at $83.26, down $0.78, or 0.94% since the insider transaction. Historical insider transactions for JB Hunt Transport Services go as follows:

  • 4-Week # shares bought: 21,726
  • 4-Week # shares sold: 38,122
  • 12-Week # shares bought: 21,726
  • 12-Week # shares sold: 113,122
  • 24-Week # shares bought: 21,726
  • 24-Week # shares sold: 155,962

The average volume for JB Hunt Transport Services has been 770,400 shares per day over the past 30 days. JB Hunt Transport Services has a market cap of $9.4 billion and is part of the services sector and transportation industry. Shares are up 13.37% year-to-date as of the close of trading on Thursday.

J.B. Hunt Transport Services, Inc., together with its subsidiaries, provides surface transportation and delivery services in the continental United States, Canada, and Mexico. The stock currently has a dividend yield of 1.06%. The company has a P/E ratio of 22.1. Currently, there are 11 analysts who rate JB Hunt Transport Services a buy, no analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on JBHT - FREE

TheStreet Quant Ratings rates JB Hunt Transport Services as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, growth in earnings per share and increase in net income. We feel its strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full JB Hunt Transport Services Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Cryolife (CRY) - FREE Research Report

Ronald C Elkins, who is Director at Cryolife, sold 2,000 shares at $14.00 on July 28, 2016. Following this transaction, the Director owned 103,586 shares meaning that the stake was reduced by 1.89% with the 2,000-share transaction.

The shares most recently traded at $14.49, up $0.49, or 3.38% since the insider transaction. Historical insider transactions for Cryolife go as follows:

  • 4-Week # shares bought: 10,000
  • 4-Week # shares sold: 10,000
  • 12-Week # shares bought: 10,000
  • 12-Week # shares sold: 15,000
  • 24-Week # shares bought: 10,000
  • 24-Week # shares sold: 18,000

The average volume for Cryolife has been 192,300 shares per day over the past 30 days. Cryolife has a market cap of $458.2 million and is part of the health care sector and health services industry. Shares are up 32.56% year-to-date as of the close of trading on Thursday.

CryoLife, Inc., together with its subsidiaries, manufactures and distributes medical devices worldwide. It also processes and distributes implantable human tissues for use in cardiac and vascular surgeries. The company operates in two segments, Medical Devices and Preservation Services. The stock currently has a dividend yield of 0.85%. The company has a P/E ratio of 43.9. Currently, there are 3 analysts who rate Cryolife a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on CRY - FREE

TheStreet Quant Ratings rates Cryolife as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, reasonable valuation levels, compelling growth in net income and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Cryolife Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Lennox International (LII) - FREE Research Report

Bedapudi Prakash, who is EVP, Chief Technology Officer at Lennox International, sold 3,667 shares at $154.90 on July 28, 2016. Following this transaction, the EVP, Chief Technology Officer owned 12,773 shares meaning that the stake was reduced by 22.31% with the 3,667-share transaction.

The shares most recently traded at $158.56, up $3.66, or 2.31% since the insider transaction. Historical insider transactions for Lennox International go as follows:

  • 4-Week # shares sold: 46,797
  • 12-Week # shares sold: 87,888
  • 24-Week # shares sold: 184,812

The average volume for Lennox International has been 373,100 shares per day over the past 30 days. Lennox International has a market cap of $6.8 billion and is part of the industrial goods sector and industrial industry. Shares are up 27.28% year-to-date as of the close of trading on Thursday.

Lennox International Inc. designs, manufactures, and markets a range of products for the heating, ventilation, air conditioning, and refrigeration markets. The company operates in three segments: Residential Heating & Cooling, Commercial Heating & Cooling, and Refrigeration. The stock currently has a dividend yield of 1.1%. The company has a P/E ratio of 25.7. Currently, there are 6 analysts who rate Lennox International a buy, no analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on LII - FREE

TheStreet Quant Ratings rates Lennox International as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, notable return on equity, good cash flow from operations and growth in earnings per share. We feel its strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Lennox International Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.